CAI
Caris Life Sciences Inc
2 super-investors hold CAI worth a combined $35M. The largest position: Stanley Druckenmiller at 1.2% of their portfolio. This quarter the cohort logged 1 buy and 0 sells on the name. Cohort Conviction Score: 40 — ranked #121 of 724 scored stocks.
Why super-investors own CAI
CAI interest in our cohort is essentially a one-man story: Stanley Druckenmiller initiated a new $34M position in 2026Q1, making it a 1.2% allocation — meaningful by his standards. Joel Greenblatt holds a token $1M stake that rounds to zero in portfolio terms. The cohort count had sat at one owner for the prior eight quarters before Druckenmiller's entry, so this is a fresh development rather than a building consensus. With only two holders and no additions from anyone else this quarter, broader interest remains minimal; the story lives or dies on whether Druckenmiller's conviction attracts followers in coming quarters.
AI-synthesized from 13F filings. Not investment advice.
Owners (2) · click any column to sort
| #↑ | Manager | % Port. | History | Value | Shares |
|---|---|---|---|---|---|
| 1 | Stanley Druckenmiller | 1.2% | — 1q | $34M | 1,894,450 |
| 2 | Joel Greenblatt | <0.1% | 3q | $1M | 77,810 |
Owners of CAI also hold
Recent activity (1)
| Manager | Move | % Port. | Δ Shares | Value | Filed |
|---|---|---|---|---|---|
| Stanley Druckenmiller | NEW | 1.2% | +100% | $34M | May 15, 2026 |
Long US equity 13F-HR filings only. CUSIP 142152107. Not investment advice.